Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-08-01

Clinical Trial Update: Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer

View source ↗

Summary

Wake Forest University Health Sciences sponsored a study evaluating cyclooxygenase-2 expression in cervical tissue from normal cervix through cervical intraepit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Cervical Cancer, Precancerous Condition | Status: WITHDRAWN